Advertisement
Advertisement

LNSR

LNSR logo

LENSAR, Inc. Common Stock

5.58
USD
Sponsored
+0.01
+0.25%
Mar 25, 16:00 UTC -4
Closed
exchange

Pre-Market

5.57

-0.01
-0.18%

LNSR Earnings Reports

Positive Surprise Ratio

LNSR beat 9 of 20 last estimates.

45%

Next Report

Next Week
Date of Next Report
Mar 31, 2026
Estimate for Q4 25 (Revenue/ EPS)
$20.71M
/
-$0.07
Implied change from Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
+23.76%
/
-95.65%

LENSAR, Inc. Common Stock earnings per share and revenue

On --, LNSR reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 20.71 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
ClearPoint Neuro, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.26
Surprise
-27.45%
logo
EDAP TMS SA
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.13
Actual
-$0.21
Surprise
-65.56%
logo
Hyperfine, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.73%
logo
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
logo
Neuronetics, Inc. Common Stock
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.10
Surprise
+8.09%
logo
InspireMD, Inc.
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.14
Surprise
+29.01%
logo
DarioHealth Corp. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$3.30
Actual
-$3.43
Surprise
-3.71%
logo
Spectral AI, Inc. Class A Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.11
Surprise
+14.86%
logo
SiNtx Technologies, Inc. Common Stock
Report Date
Mar 20, 2026 For Q4 25
Estimate
-$0.56
Actual
-$0.56
Surprise
-1.60%
logo
Tenon Medical, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.36
Actual
-$0.38
Surprise
-3.49%
FAQ
For Q-- --, LENSAR, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Mar 31, 2026.
Based on 3 analysts, LENSAR, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $20.71M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement